HONG KONG, Nov 10 (Bernama) --
Clinical Research Malaysia (CRM), a non-profit company owned by the
Ministry of Health (MOH) made its presence at the recently concluded The
3rd International Conference on Phase 1 and Early Phase Clinical Trials (ICPOEP) held on 3rd - 4th
November 2016 at the Hyatt Regency, Tsim Sha Tsui, Hong Kong. This
year’s conference organized by The University of Hong Kong Clinical
Trials Centre (HKU-CTC) attracted over 400 delegates from five
continents and 20 countries. This event provided a platform for experts
around the to share the latest trends on early & Phase 1 drug
development in various diseases.
CRM also participated in Drug Information Association (DIA) in Philadelphia, the European Society of Cardiology (ESC) in Rome and the annual European Society for Medical Oncology (ESMO) congress held in Copenhagen. It was CRM’s third time participating at DIA US while its first at the ESC and ESMO since its inception in 2012 as an enabler and facilitator to the industry and medical fraternity for the conduct of industry sponsored clinical research.
CRM showcases Malaysia’s capabilities at ESMO particularly in Oncology from 7th till 10th October 2016 to some 20,000 participants form 134 countries, 80 exhibitors and 460 invited speakers. CRM led by the Chief Executive Officer, Dr. Akhmal Yusof, and Head of Business Development, Dr. Khairul Faizi Khalid, was at ESMO to create awareness on CRM and also to to showcase what Malaysia can offer to sponsors and contract-research organizations to bring in more clinical trials into Malaysia.
CRM had the opportunity to meet with sponsor’s global team such as Novo Nordisk and Astra Zeneca to shed some light on the start of more Industry Sponsored Trials coming into Malaysia in the future. The meetings with the sponsors involved clinical operations and medical affairs team from the sponsor companies and an officer from MIDA Copenhagen, Puan Roslina Othman.
Earlier in the same year, CRM had participated in three other international clinical research-related conferences including the BioPharma Asia, DIA Japan and DIA China. These events empowered CRM to reach out to the global audience from both the medical fraternity and industry to promote Malaysia’s potential and its available resources to conduct clinical trials. Due to CRM’s global presence, the company has seen an increase in the numbers of new sponsors & CROs submitting feasibility studies to Malaysia.
About Clinical Research Malaysia
Established by Malaysian Ministry of Health in 2012, Clinical Research Malaysia exists to advance global health solutions for a brighter, more hopeful future for the people by providing speedy and reliable end-to-end clinical research support for quality studies.
Our innate understanding of the local clinical research landscape with the international standards of operations coupled with fundamental backing of the government ministries provide us an incomparable advantage to work with partners from the nascent stages of development to materialisation of the end product, in order to deliver better treatment and high skilled job opportunities.
SOURCE : Clinical Research Malaysia
FOR MORE INFORMATION, PLEASE CONTACT:
Name : Syed Hamzah Syed Noordin
Tel : +603-760 5153 (ext. 121)
Email : hamzah@clinicalresearch.my
Website : www.clincialresearch.my
--BERNAMA
CRM also participated in Drug Information Association (DIA) in Philadelphia, the European Society of Cardiology (ESC) in Rome and the annual European Society for Medical Oncology (ESMO) congress held in Copenhagen. It was CRM’s third time participating at DIA US while its first at the ESC and ESMO since its inception in 2012 as an enabler and facilitator to the industry and medical fraternity for the conduct of industry sponsored clinical research.
CRM showcases Malaysia’s capabilities at ESMO particularly in Oncology from 7th till 10th October 2016 to some 20,000 participants form 134 countries, 80 exhibitors and 460 invited speakers. CRM led by the Chief Executive Officer, Dr. Akhmal Yusof, and Head of Business Development, Dr. Khairul Faizi Khalid, was at ESMO to create awareness on CRM and also to to showcase what Malaysia can offer to sponsors and contract-research organizations to bring in more clinical trials into Malaysia.
CRM had the opportunity to meet with sponsor’s global team such as Novo Nordisk and Astra Zeneca to shed some light on the start of more Industry Sponsored Trials coming into Malaysia in the future. The meetings with the sponsors involved clinical operations and medical affairs team from the sponsor companies and an officer from MIDA Copenhagen, Puan Roslina Othman.
Earlier in the same year, CRM had participated in three other international clinical research-related conferences including the BioPharma Asia, DIA Japan and DIA China. These events empowered CRM to reach out to the global audience from both the medical fraternity and industry to promote Malaysia’s potential and its available resources to conduct clinical trials. Due to CRM’s global presence, the company has seen an increase in the numbers of new sponsors & CROs submitting feasibility studies to Malaysia.
About Clinical Research Malaysia
Established by Malaysian Ministry of Health in 2012, Clinical Research Malaysia exists to advance global health solutions for a brighter, more hopeful future for the people by providing speedy and reliable end-to-end clinical research support for quality studies.
Our innate understanding of the local clinical research landscape with the international standards of operations coupled with fundamental backing of the government ministries provide us an incomparable advantage to work with partners from the nascent stages of development to materialisation of the end product, in order to deliver better treatment and high skilled job opportunities.
SOURCE : Clinical Research Malaysia
FOR MORE INFORMATION, PLEASE CONTACT:
Name : Syed Hamzah Syed Noordin
Tel : +603-760 5153 (ext. 121)
Email : hamzah@clinicalresearch.my
Website : www.clincialresearch.my
--BERNAMA
No comments:
Post a Comment